CIM
BSX icon

Cambria Investment Management’s Boston Scientific BSX Stock Holding History

Cambria Investment Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$433K Buy
6,906
+1,895
+38% +$152K 0.02% 447
2025
Q4 		$478K Buy
+5,011
New +$491K 0.03% 423

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Cambria Investment Management's BSX Position: Q1 2026 in Review

Cambria Investment Management increased its Boston Scientific (BSX) stake by 38% in Q1 2026, buying an estimated $152K and bringing the position to 6,906 shares worth $433K. The position accounts for 0.02% of the portfolio, ranked #447.

Cambria Investment Management first reported a position in BSX in Q4 2025 and has held it in 2 quarters since. The position peaked at $478K in Q4 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Cambria Investment Management held 6,906 shares of Boston Scientific worth $433K as of Q1 2026.
  • Cambria Investment Management bought 1,895 Boston Scientific shares in Q1 2026, an estimated $152K.
  • Boston Scientific made up 0.02% of Cambria Investment Management's portfolio in Q1 2026, its #447 holding.
  • Cambria Investment Management first reported a position in Boston Scientific in Q4 2025 and has held it in 2 quarters since.
  • Cambria Investment Management's Boston Scientific position peaked at $478K in Q4 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Cambria Investment Management's 13F filing for Q1 2026, filed 15 May 2026.